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Introduction
The functional integrity of the vascular endothelium
is essential to protect against the development of
atherosclerosis. Disturbances in endothelial functions
are associated with the loss of anti-adhesive and anti-
proliferative properties of the vessel wall, vascular
inflammation, and vasoconstriction in the short term,
and lead to structural changes and the development of
atherosclerotic lesions when present chronically [10].
Early structural changes of the vascular wall can be
determined non-invasively by measuring intima-
media thickness (IMT) in the common carotid artery
(CCA) using high resolution ultrasound [4].
Successful endothelial regeneration is crucial for
the prevention of atherosclerotic lesion formation.
Until recently, it was thought that endothelial repair
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j Abstract Objectives We investigated whether qualitative or quanti-
tative alterations of the endothelial progenitor cell (EPC) pool predict
age-related structural vessel wall changes. Background We have
previously shown that age-related endothelial dysfunction is accompa-
nied by qualitative rather than quantitative changes of EPCs. Animal
studies suggest that impaired EPC functions lead to accelerated arterial
intimal thickening. Methods Intima-media thickness (IMT) was mea-
sured in the common carotid artery in our previously published groups
of younger (25 ± 1 years, n = 20) and older (61 ± 2 years, n = 20)
healthy non-smoking volunteers without arterial hypertension, hyper-
cholesterolemia, and diabetes mellitus. Endothelial progenitor cells
(EPCs, KDR+/CD34+ and KDR+/CD133+) were counted in peripheral
blood using flow cytometry. In ex vivo expanded EPCs, the function was
determined as chemotaxis to VEGF, proliferation, and survival. Results
We observed thicker IMT in older as compared to younger subjects
(0.68 ± 0.03 mm Vs. 0.48 ± 0.02 mm, P < 0.001). Importantly, there
were significant inverse univariate correlations between IMT, EPC
chemotaxis, and survival (r = )0.466 P < 0.05; r = )0.463, P < 0.01).
No correlation was observed with numbers of circulating EPCs.
Multivariate regression analysis revealed that age, mean arterial pressure
and migration of EPCs were independent predictors of IMT (R2 = 0.58).
Conclusion Impaired EPC function may lead to accelerated vascular
remodeling due to chronic impairment of endothelial maintenance.
j Key words aging – Intima-media thickness –
endothelial progenitor cells
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mechanisms constitute mainly of proliferation and
migration of mature endothelial cells. More recent
studies have shown that bone marrow-derived endo-
thelial progenitor cells (EPCs) contribute to the
regeneration and maintenance of endothelium [1].
EPCs have the ability to home to sites of ischemia or
endothelial injury and differentiate to mature endo-
thelial cells. This has led to the successful therapeutic
use of EPC and different types of circulating pro-
genitor cells in cardiovascular diseases in animal
models [8, 11] and human studies [2, 8]. Studies
have shown that the presence of cardiovascular risk
factors results in a reduced number of circulating EPC
and/or an impaired progenitor cell function [5, 7, 13].
In patients with coronary artery disease, a low num-
ber of circulating EPC has been shown to predict an
increased risk to experience cardiovascular events
[14].
Aging is associated with functional and structural
changes of the vascular wall. Concerning the role of
vascular progenitors in the development of athero-
sclerotic lesions, Rauscher et al. have demonstrated
that treatment of atherosclerosis prone ApoE-defi-
cient mice with bone marrow-derived progenitor cells
from young animals prevented atherosclerosis pro-
gression, whereas the treatment with progenitor cells
from aged animals was not effective [9]. We and
others have previously shown that a reduced number
or functional impairment of EPC contributes to the
age-related endothelial vasomotor dysfunction [6, 7].
Werner et al. have shown that the number of EPC
predicts severe coronary endothelial dysfunction
independent of classical cardiovascular risk factors
including age [15]. The aim of the presented study
was the investigation whether the number of circu-
lating EPCs or the function of ex vivo expanded EPCs
contributes to the age-related process of structural
vessel wall remodeling. Therefore, we analyzed CCA
IMT as a marker of early arteriosclerosis in the group
of old and young healthy subjects without hyperten-
sion, hypercholesterolemia, diabetes, and smoking.
Materials and methods
We studied 20 young (25 ± 1 year) and 20 old
(61 ± 2 years) healthy subjects without hypertension,
hypercholesterolemia, diabetes, and smoking as re-
ported previously [6]. IMT was measured non-inva-
sively at 1 cm proximal to the carotid bifurcation by
high-resolution ultrasound. The number of circulat-
ing EPC was determined by flow cytometry as CD34/
KDR and CD133/KDR positive cells. Repeated FACS
measurements (CD34/KDR) on identical samples
showed an intraindividual coefficient of variation of
10% within-day and 22% day-to-day. This translates
into a minimally detectable difference of 67–113 cells/
ml blood, respectively (P < 0.05, power > 0.8).
Functional characteristics were assessed after cell
culture enrichment of EPC by migration, prolifera-
tion, and EPC survival. Migratory capacity towards
VEGF was determined using a modified Boyden
chamber and proliferation was measured by a color-
imetric assay based on the cleavage of tetrazolium
salts by mitochondrial dehydrogenase. For testing
EPC survival, mononuclear cells from peripheral
blood were cultured for 4 days and adherent cells of
endothelial lineage were microscopically identified by
Ulex europaeus-agglutinin I-binding and acetylated
LDL-uptake. In some cases, blood samples provided
not enough cells to perform all culture assays. Results
are expressed as means ± standard error (SE). Com-
parisons between groups were analyzed by the un-
paired Student t test. Univariate correlations were
calculated using Pearson’s coefficient. To estimate the
predictive value of EPC function in explaining vari-
ability of vascular structure measured by IMT, a
multivariate linear regression analysis was performed.
Statistical significance was assumed at P < 0.05. All
analyses were performed with SPSS 14.0.1 (SPSS Inc.,
Chicago, IL).
Results
The clinical characteristics are presented in Table 1.
The IMT was significantly increased in old subjects as
compared to young subjects (0.68 ± 0.03 Vs.
0.48 ± 0.02 mm, P < 0.001). As described [6], the
number of circulating EPC determined as CD34/KDR
and CD133/KDR double positive cells was not differ-
ent between groups, (CD34/KDR+: 436 ± 88 Vs.
502 ± 88 cells/mL; P = 0.590; CD133/KDR+: 373 ± 52
Vs. 391 ± 68 cells/mL; P = 0.846 ). After ex vivo
expansion, almost all (>95%) adherent cells were
Table 1 Characteristics of the study population
Characteristics Young subjects
(n = 20)
Old subjects
(n = 20)
P value
Age (years) 25 ± 0.6 61 ± 1.5 < 0.001
Men 10 (50%) 7 (35%)
Body mass index (kg/m2) 22 ± 0.5 24 ± 2.4 NS
Systolic blood pressure (mmHg) 117 ± 1.5 122 ± 2.7 NS
Diastolic blood pressure (mmHg) 77 ± 1.5 81 ± 1.5 NS
Total cholesterol (mg/dL) 190 ± 5.6 220 ± 5.8 <0.001
HDL cholesterol (mg/dL) 70 ± 3.7 72 ± 3.6 NS
LDL cholesterol (mg/dL) 133 ± 5.2 142 ± 6.0 NS
Triglycerides (mg/dL) 87 ± 9.7 97 ± 8.3 NS
Plasma glucose (mg/dL) 88 ± 1.6 91 ± 2.3 NS
C-reactive protein (mg/dL) 0.05 ± 0.03 0.15 ± 0.08 NS
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positive for UEA-1 and acLDL uptake confirming the
endothelial phenotype of these cells. The proliferative
activity (0.20 ± 0.04 Vs. 0.44 ± 0.07 a.u., P = 0.013)
and chemotactic migration (80 ± 12 Vs. 157 ± 16
cells/mm2, P < 0.001) of ex vivo expanded EPCs was
reduced in old subjects as compared to young sub-
jects. Furthermore, EPC survival (absolute number of
UEA-1/acLDL positive cells) was lower in old com-
pared to young subjects (45 ± 5 Vs. 93 ± 14 cells/
mm2; P = 0.003).
To further analyze the association between vascu-
lar remodeling and EPC features, we dichotomized the
study groups based on IMT leading to young and old
age-matched groups with IMT greater and smaller
than the median, respectively (young: 0.40 ± 0.02
and 0.56 ± 0.02 mm; older: 0.57 ± 0.02 and 0.79 ±
0.02 mm, each P < 0.01) [3]. This revealed that EPC
survival in culture determined as adherent acLDL/
UEA positive cells was decreased in young individuals
with thicker IMT (126 ± 22 Vs. 63 ± 13, P = 0.002).
EPC migration was not different between young
subjects with different IMT (159 ± 21 Vs. 160 ± 22
cells/mm2, P = 0.976). In older subjects, EPC migra-
tion was lower in the group with thicker IMT (98 ± 15
Vs. 54 ± 19 cells/mm2, P = 0.011). The number of
circulating EPCs as measured by CD34/KDR or
CD133/KDR positive cells remained similar between
the groups (Fig. 1).
Univariate regression analysis revealed a signifi-
cant inverse correlation between IMT and both
migratory capacity and EPC survival (n = 28,
r = )0.466, P = 0.012; n = 36, r = )0.463, P = 0.004)
but not the proliferative activity (n = 27, r = )0.281;
P = 0.156). Furthermore, IMT correlated with age,
mean arterial pressure (MAP) and total cholesterol.
A multivariate linear regression analysis including
age, MAP, total cholesterol, circulating EPC number,
and functions of ex vivo expanded EPCs showed that
age, MAP and EPC migration were independent
predictors for IMT accounting for 58% of the total
variability of IMT (adjusted R2 = 0.576, P < 0.003;
Table 2).
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Fig. 1 EPC characteristics in young and old subjects stratified by intima-media
thickness (IMT). Young and old subjects were dichotomized by their IMT and EPC
characteristics were analyzed between age groups and within comparing
age-matched groups with different IMT (Med = Median). Whereas EPC numbers
remained similar in all groups, this revealed heterogenous differences in EPC
functions with significantly decreased in EPC survival in young individuals with
thicker IMT and impaired EPC migration in old individuals with thicker IMT as
compared to the age-matched group with thinner IMT. *P < 0.05 Vs. age-matched
group, #P < 0.05 Vs. respective young group
Table 2 Multivariate linear regression analysis
Standardized coefficient P value
Age 0.451 0.049
Mean arterial pressure 0.445 0.023
Total cholesterol )0.205 0.312
EPC number (CD34+ / KDR+) )0.349 0.063
EPC survival )0.407 0.051
EPC migration )0.433 0.043
EPC proliferation 0.006 0.936
Adjusted R2 0.576
ANOVA 0.003
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Discussion
The results of the present study show for the first time
an age-dependent inverse relationship of EPC func-
tion ex vivo, but not EPC number in circulating blood,
with manifest early arteriosclerotic vessel wall
remodeling in subjects without hypertension, hyper-
cholesterolemia, diabetes, and smoking.
Only a few studies have investigated the effect of
EPCs, putative key players in vascular repair and
maintenance, on age-dependent early atherosclerosis.
Fadini et al. have shown that lower numbers of cir-
culating CD34+/KDR+ EPCs were associated with
thicker IMT in a middle aged group of subjects with a
broad spectrum of cardiovascular risk and age-profile
[3]. In the present paper, no differences in CD34+/
KDR+ and CD133+/KDR+ EPCs was seen between old
and young subjects or between age-matched groups
with different IMT whereby the EPC number was
within the range described by Werner et al. [14]. The
discrepancy with our present results may be explained
by the fact that we have focused on aging as a sole
cardiovascular risk factor and meticulously excluded
hypertension, hypercholesterolemia, diabetes, and
smoking as these factors were shown to be associated
with decreased numbers of circulating EPCs. Other
papers reporting an inverse association between age
and EPC numbers have not excluded cardiovascular
risk factors [12, 13]. Corroborating results by Xiao
et al. we have also observed an age-dependently de-
creased EPC survival during culture as determined by
acLDL-uptake and UEA binding. This may be ex-
plained by an age-dependent decline in functional
properties of EPCs including adhesion, differentia-
tion, and/or proliferation as observed in culture. De-
spite the small n-value, our data show a robust
statistically significant association between age and
EPC migration, but not EPC numbers in blood sug-
gesting that the age-dependent functional impairment
of EPCs is more pronounced than quantitative chan-
ges. Furthermore, our data suggest that this may be a
step wise process as impaired EPC proliferation was
present even early in life and was associated with early
arteriosclerotic remodeling independent of similar
EPC numbers in circulating blood. In older subjects
with already decreased proliferation and survival an
impaired EPC migration became a dominant deter-
minant of vessel wall remodeling.
One limitation of this study and other important
studies in the field is that the number of cells in
peripheral blood is compared to the function of ex
vivo expanded EPCs representing a different sub-
group of EPCs that have differentiated ex vivo to a
more mature endothelial phenotype [3, 6, 13]. Asa-
hara et al. have previously shown that ex vivo ex-
panded EPCs are derived from blood CD34+ and
KDR+ EPCs [1]. The function of ex vivo expanded
EPCs is of potential clinical importance as the
migratory capacity was an independent determinant
of the clinical outcome when these cells were used as a
cell based therapy after myocardial infarction [2].
Taken together, our data suggest that EPC function
is not only necessary for the maintenance of vascular
function but also for vascular structure. Our current
data lend further evidence to the upcoming paradigm
that EPCs represent an integral part in the cellular
repair mechanisms for endothelial regeneration and
maintenance. Clinically, these results imply that EPC
dysfunction may be an important factor in the
development of age-related arteriosclerotic disease
and a potential biomarker for vascular lesions and
future adverse events.
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